DSKYF:OTO-Daiichi Sankyo Co Ltd (USD)

COMMON STOCK | Drug Manufacturers - General | OTC Pink

Last Closing

USD 36.41

Change

0.00 (0.00)%

Market Cap

USD 15.40B

Volume

9.80K

Analyst Target

USD 13.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Daiichi Sankyo Co Ltd., manufactures pharmaceuticals for human & veterinary use and medical tools and equipment. The Company also researches and promotes products through related companies.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-05 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
AZNCF AstraZeneca PLC

N/A

USD 246.67B
NVSEF Novartis AG

N/A

USD 206.77B
RHHVF Roche Holding AG Participation

N/A

USD 203.39B
RHHBF Roche Holding AG

N/A

USD 203.39B
RHHBY Roche Holding Ltd ADR

N/A

USD 202.85B
SNYNF Sanofi

N/A

USD 124.97B
GLAXF GSK plc

N/A

USD 94.22B
DSNKY Daiichi Sankyo Co Ltd ADR

N/A

USD 67.24B
CHGCY Chugai Pharmaceutical Co Ltd A..

N/A

USD 52.77B
CHGCF Chugai Pharmaceutical Co. Ltd

N/A

USD 50.26B

ETFs Containing DSKYF

HFXJ 0.00 % 0.30 %

N/A

N/A
JPX4:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 66.01B
JPXG:LSE 0.00 % 0.00 %

N/A

N/A
JPXU:LSE Lyxor UCITS JPX-Nikkei 40.. 0.00 % 0.00 %

N/A

USD 0.01B
JPXX:LSE Lyxor UCITS JPX-Nikkei 40.. 0.00 % 0.00 %

N/A

USD 9.86M

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 36.83% 100% F 85% B
Dividend Return 0.48% 27% F 9% A-
Total Return 37.30% 100% F 85% B
Trailing 12 Months  
Capital Gain 7.06% 71% C- 68% D+
Dividend Return 0.75% 14% F 9% A-
Total Return 7.80% 72% C 66% D+
Trailing 5 Years  
Capital Gain 123.42% 100% F 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 123.42% 97% N/A 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 14.02% 94% A 61% D-
Dividend Return 29.19% 88% B+ 68% D+
Total Return 15.17% 85% B 90% A-
Risk Return Profile  
Volatility (Standard Deviation) 43.15% 24% F 55% F
Risk Adjusted Return 67.65% 94% A 95% A
Market Capitalization 15.40B 78% C+ 98% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.